The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening

Cited by (229)

Items 101–200 of 229

1. Automated Detection of Reduced Ejection Fraction Using an ECG-Enabled Digital Stethoscope
   Ling T. Guo, Gregg S. Pressman, Spencer N. Kieu, Scott B. Marrus, George Mathew, John Prince, Emileigh Lastowski, Rosalie Victoria McDonough, Caroline Currie, Urvi Tiwari et al. · 2025 · JACC Advances
2. Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure
   Rosario Rossi, Nicola Crupi, Francesca Coppi, Daniel Enrique Monopoli, Fabio Alfredo Sgura · 2013 · Journal of the Renin-Angiotensin-Aldosterone System
3. Provider Perspectives on Artificial Intelligence–Guided Screening for Low Ejection Fraction in Primary Care: Qualitative Study
   Barbara A. Barry, Xuan Zhu, Emma Behnken, Jonathan Inselman, Karen Schaepe, Rozalina G. McCoy, David R. Rushlow, Peter A. Noseworthy, Jordan P. Richardson, Susan Curtis et al. · 2022 · JMIR AI
4. Clinical and Imaging Markers of Cardiac Function and Brain Health
   Amber Yaqub, Joshua C. Bis, Stefan Frenzel, Marisa Koini, Djass Mbangdadji, Gina Marie Peloso, Rajesh Talluri, Álvaro Alonso, Martin Bahls, Robin Bülow et al. · 2025 · Neurology
5. Cardiac resynchronization therapy for patients with mild to moderately reduced ejection fraction and left bundle branch block
   Yong‐Mei Cha, Hon-Chi Lee, Siva K. Mulpuru, Abhishek J. Deshmukh, Paul A. Friedman, Samuel J. Asirvatham, David J. Bradley, Malini Madhavan, Omar F. AbouEzzeddine, Songnan Wen et al. · 2024 · Heart Rhythm
6. Lifestyle and dietary modification for prevention of heart failure
   David L. Katz · 2004 · Medical Clinics of North America
7. Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk prediction
   Yu‐Chang Huang, Yu-Chun Hsu, Zhi‐Yong Liu, Ching‐Heng Lin, Richard Tsai, Jung‐Sheng Chen, Po‐Cheng Chang, Hao-Tien Liu, Wen-Chen Lee, Hung-Ta Wo et al. · 2023 · Frontiers in Cardiovascular Medicine
8. Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
   Monika Przewłocka‐Kosmala, Thomas Hugh Marwick, Hilda Yang, Leah M. Wright, Kazuaki Negishi, Wojciech Kosmala · 2019 · JACC. Cardiovascular imaging
9. Risk Factors for Asymptomatic Ventricular Dysfunction in Rheumatoid Arthritis Patients
   Carlos A. Garza-García, Rocío Sánchez‐Santillán, Arturo Orea‐Tejeda, Lilia Castillo‐Martínez, Canseco Eduardo, José Luís López-Campos, Candace Keirns‐Davis · 2013 · ISRN Cardiology
10. Rapid Brain Natriuretic Peptide Test and Doppler Echocardiography for Early Diagnosis of Mild Heart Failure
    Nadia Aspromonte, Vincenzo Ceci, A Chiera, Claudio Coletta, Alessandra DʼEri, Mauro Feola, Prospero Giovinazzo, Loredano Milani, Federica Noventa, Angela Beatrice Scardovi et al. · 2006 · Clinical Chemistry
11. Refocusing on the Primary Prevention of Heart Failure
    Lua Jafari, Rachel M. Suen, Sadiya S. Khan · 2020 · Current Treatment Options in Cardiovascular Medicine
12. Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction With the Use of Electrocardiographic Artificial Intelligence: A Cost-Effectiveness Approach
    Liu, Wei-Ting, Hsieh, Ping-Hsuan, Lin, Chin-Sheng, Fang, Wen-Hui, Wang, Chih-Hung, Tsai, Chien-Sung, Hung, Yi-Jen, Hsieh, Chung-Bao, Lin, Chin, Tsai, Dung-Jang · 2024 · Canadian Journal of Cardiology
13. Arterial Hypertension and Cardiac Damage
    Enrico Agabiti Rosei, Giovanni DE SIMONE, Gianfrancesco Mureddu, Bruno Trimarco, Paolo Verdecchia, Massimo Volpe · 2008 · High Blood Pressure & Cardiovascular Prevention
14. Increased plasma concentrations of N-terminal pro-brain natriuretic peptide reflect the presence of mildly reduced left ventricular diastolic function in hypertension
    Tomoo Furumoto, Satoshi Fujii, Taisei Mikami, Mamiko Inoue, Keiko Nishihara, Sanae Kaga, Shogo Imagawa, Kazutomo Goto, Kaoru Komuro, Satoshi Yamada et al. · 2005 · Coronary Artery Disease
15. Role of electrocardiography and echocardiography in prevention and predicting outcome of subjects at increased risk of heart failure
    Vitantonio Di Bello, Salvatore La Carrubba, Francesco Antonini‐Canterin, Giovanni Di Salvo, Pio Caso, Giovanni La Canna, Andrea Erlicher, Luigi Paolo Badano, Maria Francesca Romano, Concetta Zito et al. · 2013 · European Journal of Preventive Cardiology
16. Left ventricular area on non-contrast cardiac computed tomography as a predictor of incident heart failure – The Multi-Ethnic Study of Atherosclerosis
    Márcio Sommer Bittencourt, Ron Blankstein, Songshou Mao, Juan J. Rivera, Alain Gerald Bertoni, Leslee J. Shaw, Roger Scott Blumenthal, Matthew Jay Budoff, Khurram Nasir · 2016 · Journal of cardiovascular computed tomography
17. Screening echocardiograms in a senior focused value based primary care improves systolic heart failure detection and clinical management
    Reyan A. Ghany, Leonardo J. Tamariz, Gordon Chen, Alina Ghany, Emancia Forbes, Thiago Tajiri, Ana Palacio · 2017 · Cardiovascular Diagnosis and Therapy
18. The Emerging Role of Echocardiography in the Screening of Patients at Risk of Heart Failure
    Paolo Colonna, Fausto José Pinto, Margherita Sorino, Francesco Bovenzi, Carlo D’Agostino, Italo de Luca · 2005 · The American Journal of Cardiology
19. Pulse Waveform Analysis in Ocular Microcirculation by Laser Speckle Flowgraphy in Patients with Left Ventricular Systolic and Diastolic Dysfunction
    Tomoaki Shiba, Mao Takahashi, Tadashi Matsumoto, Yuichi Hori · 2018 · Journal of Vascular Research
20. Comparative sensitivities betweendifferent plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure
    W.H. Wilson Tang, Kiran J. Philip, Stanley L. Hazen, Cindy Stevenson, Michael L. Pepoy, Sarah Neale, Gary S. Francis, Frederick Van Lente, Andrew Malvern Smith, Alan H.B. Wu · 2005 · Clinical cornerstone
21. Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study
    Attilio Iacovoni, Renata De Maria, Antonello Gavazzi, Aurelia Grosu, Alessandra Fontana, Silvia Guideri, Mauro Gori, Paola Ferrari, Alessandro Filippi, Maria Rosaria Rutili et al. · 2013 · International Journal of Cardiology
22. Nuclear cardiology and heart failure
    Raffaele Giubbini, Elisa Milan, Francesco Bertagna, Fernando Mut, Marco Metra, Carlo Alberto Rodella, Maurizio Dondi · 2009 · European Journal of Nuclear Medicine and Molecular Imaging
23. Prevalence, Prognosis, and Therapeutic Implications of Unrecognized Left Ventricular Systolic Dysfunction in Patients With Anemia and Chronic Kidney Disease
    Sabha Bhatti, Abdul Hakeem, Kathryn Sullivan Dillie, Jeffery R. Cook, Su Min Chang · 2010 · Congestive Heart Failure
24. Candidate biomarkers in heart failure with reduced and preserved ejection fraction
    Christoph Sinning, Elvin Zengin, Tanja Zeller, Renate B. Schnabel, Stefan Blankenberg, Dirk Westermann · 2015 · Biomarkers
25. Asymptomatic left ventricular dysfunction and metabolic syndrome: Results from an Italian multicenter study
    Salvatore La Carrubba, MariaChiara Todaro, Concetta Zito, Francesco Antonini‐Canterin, Ines Paola Monte, Pio Caso, Paolo Colonna, Cesare DE GREGORIO, Antonio Pezzano, Frank Antonio Benedetto et al. · 2013 · Journal of Cardiovascular Echography
26. Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost‐effectiveness Analysis
    Michael J. Twiner, Alexander L. Marinica, Kenneth Kuper, Allen C. Goodman, James J. Mahn, Michael J. Burla, Aaron Brody, Justin A. Carroll, Robina Josiah Willock, John M. Flack et al. · 2017 · Academic Emergency Medicine
27. Rio de La Plata study: A multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay
    Gustavo Lorenzo Moretta, A.J. Locatelli, Liliana Gadola, Javier de Arteaga, Laura Solá, Nicola Caporale, Jorge Schargorodsky, E. Ducasse, G. Pastorino, N. Marchetta et al. · 2008 · Kidney International
28. Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
    Lori B. Daniels · 2010 · Current Cardiovascular Risk Reports
29. Improving the management of patients after myocardial infarction, from admission to discharge
    Alpesh J. Amin · 2006 · Clinical Therapeutics
30. Cardiac Resynchronization Therapy for Mild Heart Failure
    Carl R. Reynolds, Michael Robert Gold · 2011 · Circulation
31. Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients
    Salvatore La Carrubba, Francesco Antonini‐Canterin, Iacopo Fabiani, Paolo Colonna, Nicola Riccardo Pugliese, Pio Caso, Lorenzo Conte, Frank Antonio Benedetto, Concetta Zito, Rodolfo Citro et al. · 2016 · Metabolic Syndrome and Related Disorders
32. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors
    Saro H. Armenian, Thomas D. Ryan, Michel Georges Khouri · 2017 · Heart Failure Clinics
33. Accuracy of Cardiac Nurse Acquired and Measured Three-Dimensional Echocardiographic Left Ventricular Ejection Fraction: Comparison to Echosonographer
    K. Guppy-Coles, Sandhir B. Prasad, K. Smith, Ada Lo, P. Beard, Arnold C.T. Ng, John James Atherton · 2019 · Heart Lung and Circulation
34. Clinical Monitoring of Stage B Heart Failure: Echocardiography
    Erin E. Coglianese, Thomas J. Wang · 2012 · Heart Failure Clinics
35. Strategies to Screen for Stage B as a Heart Failure Prevention Intervention
    Margaret M. Redfield · 2012 · Heart Failure Clinics
36. The Prognosis of Impaired Left Ventricular Systolic Function and Heart Failure in a Middle-Aged and Elderly Population in an Urban Population Segment of Copenhagen
    Ilan E. Raymond, Jesper Mehlsen, Frants Pedersen, Jeannett Dimsits, Jørgen Jacobsen, Per Rossen Hildebrandt · 2004 · European Journal of Heart Failure
37. Cognitive Behavioral Therapy in Depressed Cardiac Surgery Patients
    Boyoung Hwang, Jo‐Ann Eastwood, Anthony McGuire, Belinda C. Chen, Rebecca Cross Bodán, Lynn V. Doering · 2014 · The Journal of Cardiovascular Nursing
38. Left ventricular dysfunction as a risk factor for cardiovascular and noncardiovascular hospitalizations in African Americans
    Saul Blecker, Kunihiro Matsushita, Ervin Ray Fox, Stuart D. Russell, Edgar R. Miller, Herman A. Taylor, Frederick L. Brancati, Josef Coresh · 2010 · American Heart Journal
39. Heart Failure Prevention and Team-based Interventions
    Paul A. Heidenreich · 2015 · Heart Failure Clinics
40. Screening for ventricular remodeling
    Douglas S. Lee, Thomas J. Wang, Ramachandran Srini Vasan · 2006 · Current Heart Failure Reports
41. Mineralocorticoid Escape by the Kidney But Not the Heart in Experimental Asymptomatic Left Ventricular Dysfunction
    Lisa C. Costello‐Boerrigter, Guido Boerrigter, Gail J. Harty, Alessandro Cataliotti, Margaret M. Redfield, John C. Jr Burnett · 2007 · Hypertension
42. Blacks and whites have a similar prevalence of reduced left ventricular ejection fraction in the general population: The Dallas Heart Study (DHS)
    David W. Markham, Daniel L. Dries, Louise Perkins King, David S. Leonard, Clyde W. Yancy, Ronald M. Peshock, DuWayne L. Willett, Richard Cooper, Mark H. Drazner · 2008 · American Heart Journal
43. Biomarkers for coronary artery disease and heart failure
    Peter A. Kavsak, Alan H.B. Wu · 2020 · Elsevier eBooks
44. Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction
    Siu‐Hin Wan, Paul M. McKie, Joshua P. Slusser, John C. Jr Burnett, David O. Hodge, Horng H. Chen · 2021 · Physiological Reports
45. Predictive Validity of NYHA and ACC/AHA Classifications of Physical and Cognitive Functioning in Heart Failure
    Ponrathi R. Athilingam, Rita D’Aoust, Cheryl Hoyt Zambroski, Susan C. McMillan, Frances Sahebzemani · 2013 · International journal of nursing
46. Integrating AI-ECG and point-of-care cardiac ultrasound for screening structural heart disease: A proof-of-concept study
    Alexandrino, Francisco B., Schlesinger, Reid, Bird, Jared, Lee, Eunjung, Deshmukh, Abhishek J., Nkomo, Vuyisile T., Oh, Jae K., Noseworthy, Peter A., Pellikka, Patricia A., Attia, Zachi et al. · 2026 · American Heart Journal
47. Stage B Heart Failure Is Ubiquitous in Emergency Patients with Asymptomatic Hypertension.
    Kimberly Souffront, Bret P. Nelson, Megan Lukas, Hans Reyes Garay, Lauren Gordon, Thalia Matos, Isabella Hanesworth, Rebecca Mantel, Claire X. Shubeck, Cassidy Bernstein et al. · 2024 · PubMed Central
48. Systolic and diastolic heart failure
    Jalal Laklaai, Oleksii Honchar, Алексей Владимирович Гончарь, Олексій Володимирович Гончарь · 2013
49. The Non-Invasive Cardiac System—Cardiac Surveyor (NICaS CS)—An Ambulatory Tool for the Diagnosis of Asymptomatic Coronary Artery Disease
    Daniel A. Goor, Samuel Sclarovsky · 2010 · US Cardiology Review
50. Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
    Michael C. Wang, Bridget Dolan, Benjamin H. Freed, Lourdes Vega, Nikola Markoski, Amy E. Wainright, Bonnie J. Kane, Laura E. Seegmiller, Katharine A. Harrington, Alana Lewis et al. · 2021 · Frontiers in Cardiovascular Medicine
51. Red cell distribution width (RDW) correlates with markers of diastolic dysfunction in patients with impaired left ventricular systolic function
    Fadi T. Alattar, Nashat Imran, Pooja H. Patel, Saad Z. Usmani, Fayez E. Shamoon · 2015 · IJC Heart & Vasculature
52. Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities
    Kai M. Eggers, Per Venge · 2011 · Pathology
53. Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP
    Siu‐Hin Wan, Isabel Torres-Courchoud, Paul M. McKie, Joshua P. Slusser, Margaret M. Redfield, John C. Jr Burnett, David O. Hodge, Horng H. Chen · 2019 · JACC Basic to Translational Science
54. β-Adrenergic receptor blockers and heart failure risk after myocardial infarction: A critical review
    Robert H. Neumayr, Paul J. Hauptman · 2009 · Current Heart Failure Reports
55. B-type Natriuretic Peptide (BNP) Is Useful in Detecting Asymptomatic Left Ventricular Dysfunction in Low-Income, Uninsured Patients
    Aurelia Macabasco‐O’Connell, Sheba Meymandi, Robert J. Bryg · 2009 · Biological Research For Nursing
56. Screening for coronary heart disease: Cardiology through the oncology looking glass
    D. Douglas Miller, Leslee J. Shaw · 2005 · Journal of Nuclear Cardiology
57. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients
    Silvio Romano, Stefano Necozione, Leonello Guarracini, Simona Fratini, Pasquale Cisternino, Ferdinando di Orio, Maria Penco · 2009 · Journal of Cardiovascular Medicine
58. Epidemiology of Heart Failure
    Raghava S. Velagaleti, Ramachandran Srini Vasan · 2010 · Elsevier eBooks
59. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients
    Peter E. Hickman, Darryl Andrew McGill, Girish Sricant Talaulikar, Balaji Hiremagalur, Jonathan Bromley, Atifur Rahman, Gus Koerbin, Emma Southcott, Julia M. Potter · 2008 · Internal Medicine Journal
60. Artificial Intelligence Based Commercial Non‐Invasive and Invasive Devices for Heart Failure Diagnosis and Prediction
    Kanchan Kulkarni, Eric M. Isselbacher, Antonis A. Armoundas · 2022 · Wiley eBooks
61. Transition from Asymptomatic to Symptomatic Systolic Chronic Heart Failure: Rationale and Design of TransitionCHF
    Anja Sandek, Frank Edelmann, Christoph Gertler, Tim Friede, Rolf Wachter, Gerd P Hasenfuss · 2024 · ESC Heart Failure
62. Deep Learning-Based Identification of Echocardiographic Abnormalities From Electrocardiograms
    Goro Fujiki, Satoshi Kodera, Naoto Setoguchi, Kengo Tanabe, Kotaro Miyaji, Shunichi Kushida, Mike Saji, Mamoru Nanasato, Hisataka Maki, Hideo Fujita et al. · 2024 · JACC Asia
63. Prevalence and Clinical Correlation of Left Ventricular Systolic Dysfunction in African Americans with Ischemic Stroke
    Saravana Devulapalli, Shariff Dunlap, Nakia Wilson, Stephen Cockburn, Mohankumar Kurukumbi, Prafulla P. Mehrotra, Annapurni Jayam‐Trouth · 2014 · Journal of Stroke and Cerebrovascular Diseases
64. Identification of patients with asymptomatic left ventricular dysfunction: 'real practice' results in primary care
    G DʼAmbrosio, Alessandro Filippi, Raffaele Labriola, Maria Stella Padula, Claudio Alberto Cricelli · 2010 · Family Practice
65. Risk Factors for Heart Failure in Young Adults
    Joel S. Landzberg, Julius M. Gardin · 2010 · Current Cardiovascular Risk Reports
66. Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step Approach
    Fiorentina Guida, Marianna Fabi, Anna Balducci, Daniele Zama, Riccardo Masetti, Federico Mercolini, Tamara Belotti, Maria Elena Cantarini, Elena Facchini, Elena Lara Legnani et al. · 2025 · Cancers
67. Smarter FoCUS: AI-guided focused cardiac ultrasound enables novice detection of left ventricular dysfunction
    Conor J. Kane, Jordan Borgeson, Christie M. Greason, Jeffrey G. Malins, DM Anisuzzaman, Gal Tsaban, Daniel Andres Schonfeld, John I. Jackson, Julia Wood, Eunjung Lee et al. · 2026 · European Heart Journal - Digital Health
68. Use of Wearable Devices for Peak Oxygen Consumption Measurement in Clinical Cardiology: Case Report and Literature Review
    Gabriella Bayshtok, Shmuel Tiosano, Ariel Furer · 2023 · Interactive Journal of Medical Research
69. Brain natriuretic peptide in the contemporary management of congestive heart failure
    Cara A. Wasywich, GILLIAN A. WHALLEY, Robert Neil Doughty · 2005 · Expert Review of Cardiovascular Therapy
70. Natriuretic peptide testing in primary care patients
    Michele Emdin, Marianna Fontana, Roberta Poletti, Alessandra Gabutti, Chiara Mammini, Andrea Rossi, Luigi Emilio Pastormerlo, Lorenzo Masi, Claudio Passino, Aldo Clerico · 2008 · Clinical Chemistry and Laboratory Medicine (CCLM)
71. Treatment of asymptomatic left ventricular dysfunction
    George Victor Moukarbel, Scott David Solomon · 2008 · Current Treatment Options in Cardiovascular Medicine
72. All Patients Older Than Age 60 Years Should Not Undergo a B-Type Natriuretic Peptide Screening Test
    Kanu Chatterjee · 2004 · The American Heart Hospital Journal
73. Comprehensive Adrenergic Blockade Post Myocardial Infarction Left Ventricular Dysfunction
    Gregg C. Fonarow · 2008 · Cardiology Clinics
74. Study of patients with iron deficiency and HF in Ireland: prevalence and treatment budget impact
    Bethany Wong, Sandra Redmond, Ciara Blaine, Carol-Ann Nugent, Lavanya Saiva, John Buckley, Jim O. O'Neill · 2021 · British Journal of Cardiology
75. Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis
    Clare Goyder, Andrea K. Roalfe, Nicholas Robert Jones, Kathryn Taylor, C. D. Plumptre, Thomas R. Fanshawe, Richard F. Hobbs, Clare J Taylor · 2019 · Wellcome Open Research
76. Disfunción sistólica ventricular izquierda asintomática
    Héctor H. Tacchi · 2007 · Redalyc (Universidad Autónoma del Estado de México)
77. Serial changes in systolic and diastolic echocardiographic indices as predictors of outcome in patients with decreased left ventricular ejection fraction
    S. Michelle Bierig, A RYAN, Ali Ziaee, Larry K. Kociolek, J Simon, S HERRMANN, Arthur J. Labovitz · 2006 · European Journal of Echocardiography
78. Asymptomatic left ventricular dysfunction and cardiopulmonary exercise testing for mortality risk prediction
    Erik Fung, Gloria H W Lau · 2022 · European Journal of Preventive Cardiology
79. A Low Serum Albumin Level Predicts Cardiovascular Events in Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction
    Mizuki Komatsu, Masayuki Okazaki, Ken Tsuchiya, Hiroshi Kawaguchi, Kosaku Nitta · 2015 · International Journal of Clinical Medicine
80. AI-ECG Detection of Structural Heart Disease in the Community Setting
    Timothy Joseph Poterucha, John Weston Hughes, Michael I. Brener, Michael L. Chuang, Nadira B. Hamid, Clayton Snyder, Julia B Thompson, Jena Ungarten, Kayo Takahashi, Brian R. Lindman et al. · 2026 · Journal of the American College of Cardiology
81. Brain Natriuretic Peptide: Structure, Action and Role in the Diagnosis and Prognosis of Heart Failure
    Emmanuel A. Andreadis, Charalampia V. Geladari · 2015 · Hospital chronicles/Hospital Chronicles
82. ABCD's of Heart Failure: Echo-ing through the First Stage
    James N. Kirkpatrick · 2010 · Journal of the American Society of Echocardiography
83. Hypertension, the J-Curve and the INVEST Trial
    Finn O. Akerström, Luis Rodrı́guez Padial · 2011 · The American Journal of Cardiology
84. Heart failure with normal left ventricular ejection fraction (HFNEF)
    2009 · Birkhäuser Basel eBooks
85. Mortality, morbidity and evidence‐based management amongst patients in regional N ew Z ealand with severe left ventricular systolic dysfunction (1997–2011)
    Brooklyn Grainger, S. White, S. Lake, Andrew W. Hamer, Nick G. Fisher, Tammy J. Pegg · 2013 · Internal Medicine Journal
86. Reducing the Burden of Stage B Heart Failure Will Require Connecting the Dots Between “Knowns” and “Known Unknowns”
    Ragavendra R. Baliga, James B. Young · 2011 · Heart Failure Clinics
87. β-blockers in Post ST Elevation Myocardial Infarction Patient with Low Left Ventricular Systolic Function: A Retrospective Study at Shahid Gangalal National Heart Centre, Kathmandu, Nepal
    Chandra Mani Adhikari · 2014 · Cardiology and Angiology An International Journal
88. Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis
    Clare Goyder, Andrea K. Roalfe, Nicholas Robert Jones, Kathryn Taylor, C. D. Plumptre, T. R. Fanshawe, Richard F. Hobbs, C. J. Taylor · 2019 · Wellcome Open Research
89. Contraceptive Management of Women with Cardiac Disease
    Autumn Davidson, Joan Ellen Briller, Julie Chor · 2014 · Springer eBooks
90. Ipertensione arteriosa e patologia cardiaca: linee guida diagnostico-terapeutiche Commissione congiunta Società Italiana dell'Ipertensione Arteriosa 1 , Società Italiana di Cardiologia 2 , Associazione Nazionale Medici Cardiologi Ospedalieri 3
    Enrico Agabiti Rosei, Giovanni DE SIMONE, Gian Francesco Mureddu, Bruno Trimarco, Paolo Verdecchia, Massimo Volpe, María Lorenza Muiesan, Ettore Ambrosioni, Giampaolo Bernini, Giovanni Cerasola et al. · 2008
91. Epilogue
    Shashank Desai, Mariell L Jessup · 2004 · Medical Clinics of North America
92. Cardiac and arterial complications
    Alicia Rovó, André Tichelli · 2021
93. AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions
    Tang, Qianwen, Deng, Kunfei, Cui, Yu, Liu, Hongjie, Qian, Bairui · 2026 · International Journal of General Medicine
94. Epidemiology and Prevention of Heart Failure and Management of Asymptomatic Left Ventricular Systolic Dysfunction
    Paul Rocchiccioli, John J.V. McMurray · 2009
95. Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients
    Paolo Pieragnoli, Giuseppe Ricciardi, Gemma Filice, Antonio Michelucci, Luigi Padeletti · 2011 · InTech eBooks
96. Noninvasive Assessment of Asymptomatic Individuals at Risk of Coronary Heart Disease. Part b
    Dhrubo Jyoti Rakhit, Thomas Hugh Marwick · 2006 · Springer eBooks
97. Childhood cancer survivors: Evidence and care
    Elske Sieswerda · 2013 · UvA-DARE (University of Amsterdam)
98. Are angiotensin-converting enzyme inhibitors and β-blockers making an impact on the epidemiology of heart failure?
    Kirkwood F. Adams · 2004 · Current Cardiology Reports
99. Diagnosis of Heart Failure: Evidence-Based Perspective
    José Marı́n-Garcı́a · 2010 · Humana Press eBooks
100. Asymptomatic systolic and diastolic dysfunction in patients with risk factors referred for echocardiography. The DAVES study by the Italian Society of Cardiovascular Echography
     Scipione Carerj, Salvatore La Carrubba, Alessandro Salustri, Maria Penco, F. Antonini Canterin, Concetta Zito, Gianfranco Pasini, Giovanni Di Salvo, Antonio Pezzano, Vitantonio Di Bello · 2012 · Journal of Cardiovascular Echography